Paul Thomen

Wednesday 6 March 2013

Global and China Human Coagulation Factor Ⅷ Industry

This is a professional and depth research report on Global and China Human Coagulation Factor VII industry. This report has firstly introduced Human Coagulation Factor VII definition classification industry chain etc related information. Then introduced Human Coagulation Factor VII manufacturing technology and product specifications, And then summary statistics Global and China major Human Coagulation Factor VII manufacturers 2010-2016 Human Coagulation Factor VII capacity production supply demand shortage and Human Coagulation Factor VII selling price cost profit margin and production value, and also introduced International and China 18 manufacturers company basic information, 2010-2016 Human Coagulation Factor VII capacity production price cost profit margin production value Global China market share etc details information. In the end, this report introduced 200K bottles/year Human Coagulation Factor VII project feasibility analysis and investment return analysis and also give related research conclusions and development trend analysis of Global and China Human Coagulation Factor VII industry. In a word, it was a depth research report on Global and China Human Coagulation Factor VII industry. And thanks to the support and assistance from Human Coagulation Factor VII industry chain (Human Coagulation Factor VII related raw materials suppliers and government related agencies etc) related experts and enterprises during Research Team survey and interviews.


Table of Content

Chapter One Human Coagulation Factor VII (AHF) Industry Overview 1
1.1 Human Coagulation Factor VII Definition 1
1.2 Human Coagulation Factor VII Product Specifications 2
1.3 Human Coagulation Factor VII Price Analysis 2
1.4 Human Coagulation Factor VII Manufacturing Process 3
1.5 Human Coagulation Factor VII Cost Structure 5
1.6 Human Coagulation Factor VII Industry Overview 6
Chapter Two Recombinant Human Coagulation Factor VII (rFVII) Industry Overview 7
2.1 Recombinant Human Coagulation Factor VII Definition 7
2.2 Recombinant Human Coagulation Factor VII Product Specifications 8
2.3 Recombinant Human Coagulation Factor VII Price Analysis 8
2.4 Recombinant Human Coagulation Factor VII Manufacturing Process 9
2.5 Recombinant Human Coagulation Factor VII Cost Structure 10
2.6 Recombinant Human Coagulation Factor VII Industry Overview 11
Chapter Three Human Coagulation Factor VII Industry Chain Analysis 12
3.1 Raw Materials Market Analysis 12
3.1.1 Plasma Volume Analysis 12
3.2 Hemophilia Patients Analysis 13
3.3 Raw Materials-Human Coagulation Factor VII -Hemophilia Patients Industry Chain Analysis 15
Chapter Four Human Coagulation Factor VII Production Supply Sales Demand Market Status and Forecast 17
4.1 Global Human Coagulation Factor VII Capacity Production Overview 17
4.2 China Human Coagulation Factor VII Capacity Production Overview 28
4.3 Europe US China Japan Korea Human Coagulation Factor VII +Recombinant Human Coagulation Factor VII Production and Market Share 31
4.4 Human Coagulation Factor VII  Recombinant Human Coagulation Factor VII Production and Market Share 33
4.5 Global and China Key Manufacturers Human Coagulation Factor VII Capacity Utilization Rate 35
4.6 China Human Coagulation Factor VII Capacity Production and Its Global Proportion 37
4.7 Global and China Human Coagulation Factor VII Demand Overview 38
4.8 Global and China Human Coagulation Factor VII Supply Demand Shortage 40
4.9 Global and China Human Coagulation Factor VII Cost Price Production Value Gross Margin 42
4.10 China Human Coagulation Factor VII Import Export Consumption 43
Chapter Five Human Coagulation Factor VII Key Manufacturers Research 44
5.1 Baxter (USA) 44
5.2 BAYER (Germany) 53
5.3 CSL Behring (USA) 57
5.4 PFIZER (USA) 71
5.5 Grifols (Spain) 75
5.6 Octapharma (Switzerland) 80
5.7 GreenCross (Korea) 84
5.8 LFB (France) 93
5.9 BPL (UK) 97
5.10 Biotest (Germany) 100
5.11 Kedrion (Italy) 104
5.12 Intersero(Germany) 107
5.13 KAKETSUKEN (Japan) 109
5.14 MTPC (Japan) 112
5.15Shanghai RAAS Blood Products Co.,Ltd (Shanghai) 114
5.16 Hualan Biological Engineering Inc. (Henan) 121
5.17 Greencross(China) (Anhui) 126
5.18 Shandong Taibang Biological (Shandong) 129
Chapter Six Human Coagulation Factor VII New Project Investment Feasibility Analysis 133
6.1 Recombinant Human Coagulation Factor VII Project SWOT Analysis 133
6.2 200K Bottle/Year Recombinant Human Coagulation Factor VII (Type:200IU) New Project Investment Feasibility Analysis 134
6.2.1 Project Name 134
6.2.2 Project Products and Scale 134
6.2.3 Project Key Buildings 135
6.2.4 Project Schedule 135
6.2.5 Project Investments 135
6.2.6 Project Feasibility and Investment Return Analysis 136
Chapter Seven Human Coagulation Factor VII Industry Research Conclusions 136

No comments:

Post a Comment

Note: only a member of this blog may post a comment.